arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

PROKIDNEY CORP.

PROK

$1.64 ▼ -0.01 (-0.61%) at close

23 Visible periods

15 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

PROKIDNEY CORP. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth -1.7%

Op. Margin —

ROIC 4.4% →

FCF / Share —

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$226.00K

↓ -1.7% —

Net Income Profit after all expenses

$-20.04M

↓ -19.7% —

Health Breakdown

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	-1.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-122%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-19.7% Weak ↓ Weak Declining Year-over-year change in net income	9.6% Fair ↑ Fair Improving Year-over-year change in net income	8.0% Fair ↑ Fair Improving Year-over-year change in net income	-32.4% Weak ↑ Weak Improving Year-over-year change in net income	-76.3% Weak ↑ Weak Improving Year-over-year change in net income	-273.2% Weak ↓ Weak Declining Year-over-year change in net income	-63.1% Weak ↓ Weak Declining Year-over-year change in net income	-37.2% Weak ↓ Weak Declining Year-over-year change in net income	74.3% Excellent ↑ Excellent Improving Year-over-year change in net income	—	63.3% Excellent ↑ Excellent Improving Year-over-year change in net income	58.8% Excellent ↑ Excellent Improving Year-over-year change in net income	45.3% Excellent ↑ Excellent Improving Year-over-year change in net income	—	-74.6% Weak ↑ Weak Improving Year-over-year change in net income	-426974.5% Weak Weak Year-over-year change in net income	-1302215.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-14.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
FCF / Net Income (x)	2.27x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.99x Excellent → Excellent Stable Free cash flow relative to reported net income Optimal: > 1x	1.93x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	2.09x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.84x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	2.33x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	1.77x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	3.11x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	3.75x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	4.73x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	3.83x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	4.4% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	4.3% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	3.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.1% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	5.4% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	4.7% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	4.4% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	3.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	2.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.4% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	3.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	2.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	2.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	3.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-335.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-334.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-163.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-15.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-11.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-6.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	-0.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	2.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-87%)	1.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-87%)	1.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	1.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	1.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	2.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-86%)	1.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-88%)	1.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-91%)	0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	0.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	1.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-93%)	0.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	2.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	—	2.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-82%)	—	—	-203.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1459%)	-164.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1198%)	-26.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-2995.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-45371.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19269.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39709.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-25785.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24486.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14352.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20038.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8070.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23308.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9954.75x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-13625.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15117.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1226.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-121.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4747.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-17081.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-101.89M	$-108.54M	$-95.32M	$-84.94M	$-97.81M	$-99.12M	—	—	$-84.39M	—	$-191.39M	$-243.55M	$-271.63M	—	$-506.33M	—	—	—	—	$-223.54K	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$208.97M	$249.94M	$270.93M	$296.18M	$326.85M	$359.67M	—	—	$320.86M	—	$385.44M	$441.94M	$468.86M	—	$509.53M	—	—	—	—	$-359.99K	—	—	—
Total Equity (USD)	$-1.02B	$-1.01B	$-1.01B	$-1.00B	$-998.55M	$-994.95M	$-979.71M	$-972.37M	$-1.10B	$-1.10B	$-1.09B	$-1.32B	$-1.60B	$-1.10B	$-1.10B	$6.54M	$20.17M	$26.92M	$10.41M	$19.68K	$0.00	$9.86M	$15.88M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$226.00K	—	$217.00K	$221.00K	$230.00K	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$1.66M	$1.84M	$1.67M	$1.47M	$1.60M	$1.57M	$1.49M	$1.27M	$1.10M	$1.15M	$807.00K	$652.00K	$832.00K	$791.00K	$627.00K	$752.00K	$710.00K	$587.00K	$401.00K	—	—	—	—
Net Income, GAAP (USD)	$-20.04M	$-19.23M	$-16.47M	$-16.55M	$-16.73M	$-21.28M	$-17.91M	$-12.51M	$-9.49M	$-5.70M	$-10.98M	$-9.12M	$-36.91M	—	$-29.93M	$-22.13M	$-67.49M	$-54.89M	$-17.14M	$-5.18K	$-5.18K	—	—
Operating Cash Flow (USD)	$-41.68M	$-32.51M	$-26.60M	$-31.42M	$-29.59M	$-24.17M	$-29.24M	$-38.29M	$-34.65M	$-25.38M	—	—	$-25.99M	$-15.76M	—	$-23.03M	$-15.46M	$-12.99M	—	$-19.84K	$-138.00	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 23 quarters

PROKIDNEY CORP.

Analytical Summary

23-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare PROK with peers